Osteoporosis in men.
The subject of osteoporosis in men is gaining international attention because it has become a significant public health issue. Women have been the focus of osteoporosis research for decades, and the majority of published data related only to women until recently. There is now significant research available supporting the importance of prevention and treatment of osteoporosis in men. This article addresses the spectrum of assessment, prevention, and treatment of this problem.
Geier
K A
KA
Webster Orthopaedic Medical Group, Jackson Arthritis Center, Oakland, California, USA.
D000328:Adult; D001364:Awareness; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000008:administration & dosage; D004164:Diphosphonates / Q000627:therapeutic use; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D000068296:Risedronic Acid; D012307:Risk Factors; D012737:Sex Factors
D004164:Diphosphonates; C028815:salmon calcitonin; D002116:Calcitonin; D000068296:Risedronic Acid; D012968:Etidronic Acid; D002118:Calcium